Replies

another version at JAMA Network. only 4 comments - not impressed, it seems:

6 May: JAMA Network: The Ethics of COVID-19 Immunity-Based Licenses (“Immunity Passports”)
by Govind Persad, JD, PhD1; Ezekie J. Emanuel, MD, PhD
Conclusions:
Immunity-based licenses have the potential to help realize important values, including enhancing the liberty of individuals who have been infected with COVID-19 without worsening the situation of those who have not been infected, maximizing benefits to individuals and society by allowing immune people to engage in economic activity, and protecting the least advantaged by allowing safer care for vulnerable populations. Importantly, immunity-based licenses do not violate equal treatment because the factors used to grant a license are not discriminatory, like race or religion, but instead grounded in relevant evidence. While immunity-based licenses require careful implementation and scientific support to be ethical in practice, nothing makes them unethical in principle.

Conflict of Interest Disclosures: Dr Persad reported receiving grants from The Greenwall Foundation. Dr Emanuel reported receiving speaking fees from numerous entities, stock ownership in Nuna, investment partnership in Oak HC/FT, and receipt of grants from Hawaii Medical Service Association and Oscar Health
https://jamanetwork.com/journals/jama/fullarticle/2765836

Wikipedia: JAMA The Journal of the American Medical Association
On 11 July 2016, JAMA published an article by Barack Obama entitled, United States Health Care Reform: Progress to Date and Next Steps,[8] which was the first academic paper ever published by a sitting U.S. president. The article was not subject to blind peer-review. It argued for specific policies that future presidents could pursue in order to improve national health care reform implementation.
https://en.wikipedia.org/wiki/JAMA_(journal)